the pharmacokinetics of caffeine was examined in 13 premature infants ( gestational age 25-34 weeks , birth weight 920-2060 g , postnatal age 1-42 days ) who received the drug for treatment of apnoea .
C0006644
caffeine
C0003578
apnoea